418
Participants
Start Date
May 14, 2024
Primary Completion Date
June 17, 2025
Study Completion Date
June 17, 2026
Sonelokimab
Sonelokimab
Placebo
Placebo
Clinical Site, Woluwe-Saint-Lambert
Clinical Site, Sofia
Clinical Site, Sofia
Clinical Site, Sofia
Clinical Site, Sofia
Clinical Site, Leuven
Clinical Site, Liège
Clinical Site, Stara Zagora
Clinical Site, Ghent
Clinical Site, New York
Clinical Site, Berlin
Clinical Site, Cadiz
Clinical Site, Córdoba
Clinical Site, Prague
Clinical Site, Santiago de Compostela
Clinical Site, Granada
Clinical Site, Granada
Clinical Site, Hamburg
Clinical Site, Dijon
Clinical Site, Baltimore
Clinical Site, Lübeck
Clinical Site, Kiel
Clinical Site, Besançon
Clinical Site, Morgantown
Clinical Site, Madrid
Clinical Site, Madrid
Clinical Site, Madrid
Clinical Site, Madrid
Clinical Site, Alcorcón
Clinical Site, Málaga
Clinical SIte, Brest
Clinical Site, Toulouse
Clinical Site, Hialeah
Clinical Site, Miami
Clinical Site, Aventura
Clinical Site, Tampa
Clinical Site, Bielefeld
Clinical Site, Montpellier
Clinical Site, Ocala
Clinical Site, Birmingham
Clinical Site, Murfreesboro
Clinical Site, Seville
Clinical Site, Murray
Clinical Site, Saint-Priest-en-Jarez
Clinical Site, Columbus
Clinical Site, Bochum
Clinical Site, Valencia
Clinical Site, Valencia
Clinical Site, Plainfield
Clinical Site, Manises
Clinical Site, Canton
Clinical Site, Waterford
Clinical Site, Clarkston
Clinical Site, Bad Bentheim
Clinical Site, Bramsche
Clinical Site, Wroclaw
Clinical Site, Milwaukee
Clinical Site, New Brighton
Clinical Site, Fargo
Clinical Site, Skokie
Clinical Site, Darmstadt
Clinical Site, Omaha
Clinical Site, Lyon
Clinical Site, Baton Rouge
Clinical Site, Le Mans
Clinical Site, North Little Rock
Clinical Site, Plano
Clinical Site, Rouen
Clinical Site, San Antonio
Clinical Site, Augsburg
Clinical Site, Las Vegas
Clinical Site, Santa Monica
Clinical Site, Trnava
Clinical Site, Antony
Clinical Site, Fountain Valley
Clinical Site, Saint-Mandé
Clinical Site, Würzburg
Clinical Site, Ann Arbor
Clinical Site, Dallas
Clinical Site, Calgary
Clinical Site, Edmonton
Clinical Site, Guelph
Clinical Site, Peterborough
Clinical Site, Richmond Hill
Clinical Site, Toronto
Clinical Site, Windsor
Clinical Site, Saskatoon
Clinical Site, Ostrava
Clinical Site, Prague
Clinical Site, Dresden
Clinical Site, Gera
Clinical Site, Dublin
Clinical Site, Rotterdam
Clinical Site, Chorzów
Clinical Site, Katowice
Clinical Site, Kielce
Clinical Site, Olsztyn
Clinical Site, Poznan
Clinical Site, Szczecin
Clinical Site, Warsaw
Clinical Site, Alicante
Clinical Site, Badalona
Clinical Site, Barcelona
Clinical Site, Barcelona
Clinical Site, Barcelona
Clinical Site, Granollers
Lead Sponsor
MoonLake Immunotherapeutics AG
INDUSTRY